Navigation Links
Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
Date:11/6/2008

SAN DIEGO, Nov. 6 /PRNewswire/ -- Valor Medical, Inc., a medical device company that has developed a liquid embolic technology for the treatment of cerebral aneurysms, announced today that they have successfully raised $1.4 million in capital through a convertible debt offering. Valor's Chief Executive Officer, Clark Adams stated, "Valor's Board and shareholders had approved raising $1.4 million in capital that will be used to complete clinical trials needed for commercial approval in Europe. Reaching the $1.4 million limit went rather quickly and, unfortunately, could not accommodate all potential investors."

Valor also announced that they have received ISO 13485 certification. This certification is a major step toward commercialization in Europe. Mr. Adams explained that the ISO certification is needed before a medical device company can apply for the European CE Mark that must be received before they are allowed to sell product in Europe. Valor Medical expects to receive CE Mark late 2009 and will begin sales at that time.

"Clinical trial results to date have been positive and the reduction in surgery time is dramatic. The accumulated patient implant time to date has reached over 6.4 years," Mr. Adams announced. Valor Medical expects to sell product by the end of 2009 and will be raising additional capital as the company ramps up sales, marketing and distribution in Europe.

For additional information, visit Valor Medical's web site, http://www.valormedical.com


'/>"/>
SOURCE Valor Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
2. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
3. Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
6. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
7. Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
8. Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
9. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
10. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Md. , March 27, 2017  The ... billion for 2016, according to a new report ... medical lab testing is performed to evaluate disease ... individual therapy, among other reasons.  The healthcare market ... Market , provides an overview of the ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... method to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, the ... lead to new and improved ways of treating coronary artery disease (CAD). Lam ...
(Date:3/24/2017)... March 24, 2017 MiMedx Group, Inc. (NASDAQ: ... human placental tissue allografts and patent-protected processes to develop ... of healthcare, announced today  that it will present at ... , NY.  Parker H. "Pete" Petit, Chairman and ... Christopher M. Cashman , EVP and Chief Commercialization ...
(Date:3/24/2017)... 2017 On Thursday, March 23, ... 5,817.69, down 0.07%; the Dow Jones Industrial Average edged ... 500 closed at 2,345.96, marginally dropping 0.11%. US markets ... green, 4 sectors finished in red, and 1 sector ... initiated reports coverage on the following Biotechnology equities: BioDelivery ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOG´s multi-biometrics system.   Continue ... ...
Breaking Biology News(10 mins):